Bioventus Inc. Quarterly Liabilities in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Bioventus Inc. quarterly Liabilities history and growth rate from Q4 2020 to Q2 2024.
  • Bioventus Inc. Liabilities for the quarter ending June 29, 2024 was $603M, a 0.08% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $603M -$510K -0.08% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $577M -$70.2M -10.9% Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $590M -$371M -38.6% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $585M -$434M -42.6% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $604M -$85M -12.3% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 $647M -$28.2M -4.17% Apr 1, 2023 10-Q 2023-05-16
Q4 2022 $960M +$342M +55.4% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $1.02B +$595M +140% Oct 1, 2022 10-Q 2022-11-21
Q2 2022 $689M +$261M +61.2% Jul 2, 2022 10-Q 2022-08-12
Q1 2022 $675M +$252M +59.7% Apr 2, 2022 10-Q 2022-05-11
Q4 2021 $618M +$268M +76.5% Dec 31, 2021 10-K 2024-03-12
Q3 2021 $424M Oct 2, 2021 10-Q 2021-11-10
Q2 2021 $427M Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $423M Apr 3, 2021 10-Q 2021-05-13
Q4 2020 $350M Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.